Results 281 to 290 of about 180,829 (383)
Switching from anti-CD20 therapies to cladribine and vice versa - Analysis of a German relapsing multiple sclerosis cohort. [PDF]
Konen FF +15 more
europepmc +1 more source
Etiology, pathogenesis and treatment of peri‐implantitis: A European perspective
Abstract Peri‐implantitis is a plaque‐associated pathological condition occurring in tissues around dental implants. It is characterized by inflammation in the peri‐implant mucosa and progressive loss of supporting bone. Over the last 30 years, peri‐implantitis has become a major disease burden in dentistry.
Tord Berglundh +3 more
wiley +1 more source
Abstract Hundreds of millions of people have one or more missing teeth. Consequently, a substantial number of patients undergo implant therapy each year. However, technical complications and soft tissue inflammation associated with the implant abutment or the type of restoration can lead to bone loss and, ultimately, implant failure.
Yasir Nabeel Al‐Mohammad +13 more
wiley +1 more source
Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up. [PDF]
Colucci M +10 more
europepmc +1 more source
HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni +9 more
wiley +1 more source
Evaluation of CD3 and CD20 Lymphocytes and Mast Cells in the Microenvironment of Central Giant Cell Granuloma, Peripheral Giant Cell Granuloma, and Giant Cell Tumor of Bone. [PDF]
Fayaq KA, Gharib BT.
europepmc +1 more source
Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients
Patients with lymphoma undergoing CD19 CAR T‐cell therapy experience prolonged hypogammaglobulinemia and B‐cell aplasia. We investigate its impact on immunity against measles virus (MeV), mumps virus (MuV), rubella virus (RuV), varicella‐zoster virus (VZV), pneumococcal capsular polysaccharide, Haemophilus influenzae type B (Hib), and tetanus toxoid ...
Hayley Foy‐Stones +15 more
wiley +1 more source

